PD-1 inhibitor-related pneumonitis in lymphoma patients treated with single-agent pembrolizumab therapy

Br J Haematol. 2018 Mar;180(5):752-755. doi: 10.1111/bjh.14441. Epub 2016 Nov 11.
No abstract available

Keywords: PD-1 inhibitor; immune-related adverse event; lymphoma; pembrolizumab; pneumonitis.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Female
  • Humans
  • Lymphoma / drug therapy*
  • Male
  • Middle Aged
  • Pneumonia / chemically induced*
  • Pneumonia / drug therapy

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab